Skip to main content
Bovine Treatment System Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 2024-2028

Bovine Treatment System Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 2024-2028

Published: Nov 2023 161 Pages SKU: IRTNTR76786

Market Overview at a Glance

$3.82 B
Market Opportunity
5.51%
CAGR
4.88
YoY growth 2023-2024(%)

Bovine Treatment System Market Size 2024-2028

The global bovine treatment system market size is estimated to grow by USD 3.82 billion at a CAGR of 5.51% between 2023 and 2028. 

The cattle industry plays a significant role in providing meat and dairy products for human consumption. As the global population increases, so does the demand for animal products. This growth in the livestock industry necessitates effective animal healthcare / veterinary treatment systems to maintain the health and productivity of cattle and improve cattle healthcare. Livestock provides a significant source of protein for human consumption. The global trend of urbanization has led to more people living in cities. Urban areas often have a higher demand for processed and convenience foods, which often contain animal products. Advances in agriculture and animal husbandry, including livestock feeding system, breeding, nutrition, and disease control, have improved the efficiency of livestock production, which is expected to drive the growth of the bovine treatment system market during the forecast period. It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Bovine Treatment System Market during the Forecast Period?

Bovine Treatment System Market Size

 Request Free Sample

Market Segmentation

The bovine treatment system market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. The market is evolving rapidly, driven by automation and digitalization in smart laboratories and veterinary diagnostics. Advanced imaging services and liquid biopsies are transforming the way veterinary professionals diagnose and treat diseases like bovine mastitis, bovine viral diarrhea, and bovine tuberculosis (bTB). Artificial intelligence technologies are being applied in point of care products for quicker, more accurate results.  Cattle Farmer now use management systems for improved milk production and cattle counts, monitoring conditions like clinical mastitis and animal borne disorders. Immunoassay kits, PCR reagents, and hemagglutination inhibition assays aid in diagnosing diseases like foot and mouth disease. The market also includes tests for goats/sheep and human diseases like Johne's disease and human tuberculosis in veterinary settings.

  • Type Outlook
    • Pharmaceutical and biologicals
    • Nutritional supplements
    • Management system
  • End-user Outlook
    • Dairy farm
    • Veterinary hospitals and clinics
    • Beef farm
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest Of World (ROW)
      • Brazil
      • Argentina 
      • Australia 

By Type Analysis

The market share growth by the pharmaceutical and biologicals segment will be significant during the forecast period. Cattle are valuable assets in the agricultural industry, providing meat, milk, and other products. Drugs and vaccines that improve cattle health and productivity, such as growth promoters and fertility-enhancing medications, are in demand to maximize the return on investment for farmers. Farmers are increasingly focused on maintaining the health and well-being of their cattle.

Bovine Treatment System Market Size

Get a glance at the market contribution of various segments Download PDF Sample

The pharmaceutical and biologicals segment segment was the largest and was valued at USD 7.12 billion in 2018. A healthy herd is more productive and profitable. This drives the demand for drugs and vaccines that address specific health issues, such as respiratory diseases, gastrointestinal problems, and reproductive disorders. Vaccines and non-antibiotic treatment options are becoming more important in managing cattle health, especially in intensive livestock operations. The increased demand for drugs and vaccines for bovine treatment and prevention is expected to continue during the forecast period as the cattle industry strives to maintain the health, welfare, and productivity of livestock, meet regulatory requirements, and respond to consumer preferences for safer and more ethically produced meat and dairy products. Due to all such factors, the pharmaceutical and biologicals segment of the market is expected to grow during the forecast period.

End-user Analysis

Dairy farmers prioritize the health and well-being of their cattle, as healthy cows are more productive and produce higher-quality milk. Bovine treatment systems play a vital role in ensuring that cows are healthy and free from diseases. Regular veterinary care and health monitoring are essential in preventing diseases and addressing health issues early. The demand for bovine treatment systems in dairy farming is expected to continue to grow as the industry focuses on improving efficiency, animal health, and milk quality, which, in turn, will have a positive impact on the growth of the market during the forecast period.

Regional Analysis

Bovine Treatment System Market Share by Geography

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. North America has a sizable and diverse cattle industry that includes both beef and dairy production. This diversity necessitates comprehensive healthcare and management solutions for cattle. There is a growing emphasis on the health and welfare of cattle in North America. Both consumers and producers are increasingly concerned about animal well-being, and bovine treatment systems are vital for maintaining high standards in these areas. Preventing diseases in cattle is a top priority for the North American cattle industry. Bovine treatment systems are used to implement vaccination programs, disease monitoring, and biosecurity measures to prevent and control diseases. Consumers in North America are increasingly interested in ethically raised and sustainably sourced beef and dairy products.

In addition, the demand for bovine treatment systems in North America is expected to continue to grow as the cattle industry evolves and adapts to changing consumer preferences, regulatory requirements, and sustainability objectives, which, in turn, will boost the growth of the regional bovine treatment system market during the forecast period.

Key Bovine Treatment System Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Boehringer Ingelheim International GmbH - The company offers bovine treatment system such as Anafen injection 100mg or ML, Bio-Mycin 200, Bovikalc, and Cefa-Dri.

  • Advanced Animal Diagnostics
  • Armenta, Bio-Vet
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • Endovac Animal Health
  • Forte Healthcare Ltd.
  • Huvepharma EOOD
  • ImmuCell Corp.
  • Merck KGaA
  • Neogen Corp.
  • Nimrod Veterinary Products Ltd.
  • Norbrook Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Vetoquinol SA
  • Virbac Group
  • West Way Health
  • Zoetis Inc
  • HIPRA S A

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamic and Customer Landscape

There are multiple factors influencing market growth. Reports provide data with forecast and historical 2018 to 2022.

Key  Market Drivers

Animal welfare concerns are notably driving the market growth. There is a growing focus on the welfare of farm animals, including bovines. Consumers, animal rights organizations, and regulators are increasingly concerned about the ethical treatment of livestock. Veterinary treatment systems play a critical role in ensuring that cattle receive appropriate care, pain management, and disease prevention. Animal welfare advocates and farmers alike are increasingly focused on reducing stress and discomfort in cattle. Treatment systems that can manage pain, monitor stress levels, and provide comfort to animals are in demand. Ensuring cattle receive proper nutrition is a key aspect of animal healthcare.

Moreover, treatment systems may include features for monitoring and optimizing the nutritional needs of cattle, promoting better health and growth. Thus, the growing concern for animal health will have a positive impact on the growth of the market during the forecast period.

Significant  Market Trends

Technological advances in treatment method is an emerging trend shaping the market growth. Advances in technology have led to more sophisticated veterinary treatment systems. These systems may include digital diagnostic tools, telemedicine options, data analytics, and automated monitoring, making it easier to care for cattle efficiently. Diagnosis is an integral part of disease prevention and management, as a minor outbreak of disease can spread quickly and pose a threat to the entire population in the vicinity. Disease diagnosis of an animal forms the connecting link between the cause of and the cure for the disease.

However, there is a requirement for rapid methods that can provide answers related to disease in terms of its cause and the probable solution. Hence, diagnostic methods should fulfill the prerequisites of simplicity, speed, sensitivity, reproducibility, specificity, and low cost. Thus, the growing technological advancements will drive the growth of the market during the forecast period. 

Major Market Challenges

The regularity hurdle associated with animal drug development is a significant challenge hindering market growth. Animal healthcare drugs have to go through a rigorous approval process conducted by regulatory agencies, such as the U.S. Food and Drug Administration (FDA). This process involves extensive testing to demonstrate safety and efficacy. Manufacturers of animal healthcare drugs need to adhere to good manufacturing practices (GMP) standards to ensure the quality, safety, and consistency of their products. Regulations often require reporting of adverse events associated with the use of animal drugs. This helps monitor safety and identify potential issues.

Additionally, such regulations are intended to ensure that animal drugs are developed and manufactured to high standards of safety, efficacy, and quality. Compliance with these regulations is crucial for the responsible development, approval, and use of medications in animal healthcare. Thus, stringent regulation on drug development will hamper the growth of the market during the forecast period.

Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

Bovine Treatment System Market Share by Geography

Global Bovine Treatment System Market Customer Landscape

Market Analyst Overview

The Veterinary Diagnostics market plays a crucial role in improving bovine diagnostics and supporting cattle farmers in managing their herds for food and commercial products like meat and dairy products. The prevalence of bovine mastitis, including dairy mastitis and clinical mastitis, has raised concerns, contributing to higher mortality in cattle. Advanced surveillance programs and management systems help monitor milk production and track cattle counts, while point of care products and imaging services assist in early detection.

Technological advancements, such as automation, digitalization, and artificial intelligence technologies, are transforming smart laboratories. The use of liquid biopsies is enhancing animal health and addressing animal borne disorders. Veterinary professionals, guided by strong ethics and a commitment to animal health diagnostic and welfare, use these tools to reduce bovine treatment issues. The market is driven by skilled professionals utilizing sophisticated tools and devices in veterinary medicine and veterinary practices. Veterinary clinics rely on advanced diagnostics like immunoassay kits, PCR reagents and kits, and the hemagglutination inhibition assay to detect diseases in cattle. Techniques like polymerase chain reaction help identify pathogens like mycobacteria, which are responsible for various infections in cattle, such as bovine mastitis.

Comprehensive cattle tests and goat/sheep tests are crucial for disease control and management, including treatments for bovine mastitis and sub-clinical mastitis applications. These innovations in diagnostics allow for better disease management and improve the overall health of livestock.

Bovine Treatment System Market Scope

Report Coverage

Details

Page number

161

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.51%

Market Growth 2024-2028

USD 3.82 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

4.88

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 39%

Key countries

US, Germany, UK, France, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Thermo Fisher Scientific Inc., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and HIPRA S A

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market  between 2024 and 2028
  • Precise estimation of the  market size and its contribution of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the market growth analysis of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global bovine treatment system market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global bovine treatment system market 2018 - 2022 ($ million)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Pharmaceutical and biologicals - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Pharmaceutical and biologicals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 35: Data Table on Pharmaceutical and biologicals - Market size and forecast 2023-2028 ($ million)
      • Exhibit 36: Chart on Pharmaceutical and biologicals - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Pharmaceutical and biologicals - Year-over-year growth 2023-2028 (%)
    • 6.4 Nutritional supplements - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Nutritional supplements - Market size and forecast 2023-2028 ($ million)
      • Exhibit 39: Data Table on Nutritional supplements - Market size and forecast 2023-2028 ($ million)
      • Exhibit 40: Chart on Nutritional supplements - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Nutritional supplements - Year-over-year growth 2023-2028 (%)
    • 6.5 Management system - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Management system - Market size and forecast 2023-2028 ($ million)
      • Exhibit 43: Data Table on Management system - Market size and forecast 2023-2028 ($ million)
      • Exhibit 44: Chart on Management system - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Management system - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Type
      • Exhibit 46: Market opportunity by Type ($ million)
      • Exhibit 47: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 50: Chart on Comparison by End-user
      • Exhibit 51: Data Table on Comparison by End-user
    • 7.3 Dairy farm - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Dairy farm - Market size and forecast 2023-2028 ($ million)
      • Exhibit 53: Data Table on Dairy farm - Market size and forecast 2023-2028 ($ million)
      • Exhibit 54: Chart on Dairy farm - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Dairy farm - Year-over-year growth 2023-2028 (%)
    • 7.4 Veterinary hospitals and clinics - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Veterinary hospitals and clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 57: Data Table on Veterinary hospitals and clinics - Market size and forecast 2023-2028 ($ million)
      • Exhibit 58: Chart on Veterinary hospitals and clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Veterinary hospitals and clinics - Year-over-year growth 2023-2028 (%)
    • 7.5 Beef farm - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Beef farm - Market size and forecast 2023-2028 ($ million)
      • Exhibit 61: Data Table on Beef farm - Market size and forecast 2023-2028 ($ million)
      • Exhibit 62: Chart on Beef farm - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Beef farm - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 64: Market opportunity by End-user ($ million)
      • Exhibit 65: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 UK - Market size and forecast 2023-2028
      • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.10 China - Market size and forecast 2023-2028
      • Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 9.11 France - Market size and forecast 2023-2028
      • Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ million)
      • Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Advanced Animal Diagnostics
              • Exhibit 115: Advanced Animal Diagnostics - Overview
              • Exhibit 116: Advanced Animal Diagnostics - Product / Service
              • Exhibit 117: Advanced Animal Diagnostics - Key offerings
            • 12.4 Bio-Vet
              • Exhibit 118: Bio-Vet - Overview
              • Exhibit 119: Bio-Vet - Product / Service
              • Exhibit 120: Bio-Vet - Key offerings
            • 12.5 Boehringer Ingelheim International GmbH
              • Exhibit 121: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 122: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 123: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 124: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 125: Boehringer Ingelheim International GmbH - Segment focus
            • 12.6 Ceva Sante Animale
              • Exhibit 126: Ceva Sante Animale - Overview
              • Exhibit 127: Ceva Sante Animale - Product / Service
              • Exhibit 128: Ceva Sante Animale - Key offerings
            • 12.7 Elanco Animal Health Inc.
              • Exhibit 129: Elanco Animal Health Inc. - Overview
              • Exhibit 130: Elanco Animal Health Inc. - Product / Service
              • Exhibit 131: Elanco Animal Health Inc. - Key offerings
            • 12.8 Endovac Animal Health
              • Exhibit 132: Endovac Animal Health - Overview
              • Exhibit 133: Endovac Animal Health - Product / Service
              • Exhibit 134: Endovac Animal Health - Key offerings
            • 12.9 HIPRA S A
              • Exhibit 135: HIPRA S A - Overview
              • Exhibit 136: HIPRA S A - Product / Service
              • Exhibit 137: HIPRA S A - Key offerings
            • 12.10 ImmuCell Corp.
              • Exhibit 138: ImmuCell Corp. - Overview
              • Exhibit 139: ImmuCell Corp. - Business segments
              • Exhibit 140: ImmuCell Corp. - Key offerings
              • Exhibit 141: ImmuCell Corp. - Segment focus
            • 12.11 Merck KGaA
              • Exhibit 142: Merck KGaA - Overview
              • Exhibit 143: Merck KGaA - Business segments
              • Exhibit 144: Merck KGaA - Key news
              • Exhibit 145: Merck KGaA - Key offerings
              • Exhibit 146: Merck KGaA - Segment focus
            • 12.12 Nimrod Veterinary Products Ltd.
              • Exhibit 147: Nimrod Veterinary Products Ltd. - Overview
              • Exhibit 148: Nimrod Veterinary Products Ltd. - Product / Service
              • Exhibit 149: Nimrod Veterinary Products Ltd. - Key offerings
            • 12.13 Norbrook Laboratories Ltd.
              • Exhibit 150: Norbrook Laboratories Ltd. - Overview
              • Exhibit 151: Norbrook Laboratories Ltd. - Product / Service
              • Exhibit 152: Norbrook Laboratories Ltd. - Key offerings
            • 12.14 Thermo Fisher Scientific Inc.
              • Exhibit 153: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 154: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 155: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 156: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 157: Thermo Fisher Scientific Inc. - Segment focus
            • 12.15 Vetoquinol SA
              • Exhibit 158: Vetoquinol SA - Overview
              • Exhibit 159: Vetoquinol SA - Business segments
              • Exhibit 160: Vetoquinol SA - Key news
              • Exhibit 161: Vetoquinol SA - Key offerings
              • Exhibit 162: Vetoquinol SA - Segment focus
            • 12.16 Virbac Group
              • Exhibit 163: Virbac Group - Overview
              • Exhibit 164: Virbac Group - Business segments
              • Exhibit 165: Virbac Group - Key news
              • Exhibit 166: Virbac Group - Key offerings
              • Exhibit 167: Virbac Group - Segment focus
            • 12.17 Zoetis Inc.
              • Exhibit 168: Zoetis Inc. - Overview
              • Exhibit 169: Zoetis Inc. - Business segments
              • Exhibit 170: Zoetis Inc. - Key news
              • Exhibit 171: Zoetis Inc. - Key offerings
              • Exhibit 172: Zoetis Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 173: Inclusions checklist
                • Exhibit 174: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 175: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 176: Research methodology
                • Exhibit 177: Validation techniques employed for market sizing
                • Exhibit 178: Information sources
              • 13.5 List of abbreviations
                • Exhibit 179: List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Bovine Treatment System market growth will increase by 3819.54 million during 2024-2028.

              The Bovine Treatment System market is expected to grow at a CAGR of 5.51% during 2024-2028.

              Bovine Treatment System market is segmented by Type( Pharmaceutical and biologicals, Nutritional supplements, Management system) End-user( Dairy farm, Veterinary hospitals and clinics, Beef farm)

              Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Thermo Fisher Scientific Inc., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., HIPRA S A are a few of the key vendors in the Bovine Treatment System market.

              North America will register the highest growth rate of 38.79% among the other regions. Therefore, the Bovine Treatment System market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US, Germany, UK, France, China

              • Livestock industry growthThe cattle industry plays a significant role in providing meat and dairy products for human consumption. As the global population increases is the driving factor this market.
              • so does the demand for animal products. This growth in the livestock industry necessitates effective veterinary treatment systems to maintain the health and productivity of cattle. Livestock provides a significant source of protein for human consumption. The global trend of urbanization has led to more people living in cities. Urban areas often have a higher demand for processed and convenience foods is the driving factor this market.
              • which often contain animal products. Advances in agriculture and animal husbandry is the driving factor this market.
              • including breeding is the driving factor this market.
              • nutrition is the driving factor this market.
              • and disease control is the driving factor this market.
              • have improved the efficiency of livestock production is the driving factor this market.
              • which is expected to propel the growth of the global bovine treatment system market during the forecast period. is the driving factor this market.

              The Bovine Treatment System market vendors should focus on grabbing business opportunities from the Pharmaceutical and biologicals segment as it accounted for the largest market share in the base year.
              RIA - Research AI Assistant
              Ask RIA